<?xml version="1.0" encoding="UTF-8"?>
<legiscan><status></status><bill><bill_id>604806</bill_id><change_hash>aebad2a7845e1e4556aec97c9e301604</change_hash><session><session_id>1083</session_id><session_name>2014 Regular Session</session_name></session><url>http://legiscan.com/MS/bill/HB1268/2014</url><state_link>http://billstatus.ls.state.ms.us/2014/pdf/history/HB/HB1268.xml</state_link><completed>1</completed><status>6</status><status_date>2014-02-04</status_date><progress><step><date>2014-01-20</date><event>1</event></step><step><date>2014-01-20</date><event>9</event></step><step><date>2014-02-04</date><event>6</event></step></progress><state>MS</state><state_id>24</state_id><bill_number>HB1268</bill_number><bill_type>B</bill_type><body>H</body><body_id>57</body_id><current_body>H</current_body><current_body_id>57</current_body_id><title>Pharmacists; may substitute prescription biosimilar product under certain conditions.</title><description>An Act To Codify Section 73-21-118, Mississippi Code Of</description><committee/><history><step><date>2014-01-20</date><action>Referred To Public Health and Human Services</action><chamber>H</chamber><chamber_id>57</chamber_id><importance>1</importance></step><step><date>2014-02-04</date><action>Died In Committee</action><chamber>H</chamber><chamber_id>57</chamber_id><importance>1</importance></step></history><sponsors><sponsor><people_id>6553</people_id><name>Bobby Howell</name><role_id>1</role_id><ftm_id>0</ftm_id><sponsor_type_id>1</sponsor_type_id><sponsor_order>1</sponsor_order></sponsor></sponsors><texts><text><doc_id>936526</doc_id><date>2014-01-24</date><type>Introduced</type><mime>text/html</mime><url>http://legiscan.com/MS/text/HB1268/id/936526</url><state_link>http://billstatus.ls.state.ms.us/documents/2014/html/HB/1200-1299/HB1268IN.htm</state_link></text></texts></bill></legiscan>
